Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study-Reference-Cited by-同舟云学术

Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study

Published:2015-04-29 Issue:9 Volume:54 Page:1673-1679
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Kommireddy Sirisha,Bhyravavajhala Srinivas,Kurimeti Kishorebabu,Chennareddy Srinivasa,Kanchinadham Suresh,Rajendra Vara Prasad Irlapati,Rajasekhar Liza

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/9/1673/9449564/kev097.pdf

Reference19 articles.

1. Pulmonary Arterial Hypertension Related to Connective Tissue Disease

2. Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

3. Chemokine RANTES in Severe Pulmonary Arterial Hypertension

4. CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

5. Tanaka E Harigai M Tanaka M . Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 2002;29:282-7.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive Care Unit Management of Right Heart Failure and Lung Transplantation for Pulmonary Hypertension;Current Respiratory Medicine Reviews;2024-08

2. Phenotypes in pulmonary hypertension;European Respiratory Journal;2024-07-04

3. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines;Arthritis Research & Therapy;2024-05-27

4. Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats;IRAN J BASIC MED SCI;2024

5. Systemic Lupus Erythematosus-related Lung Disease;Seminars in Respiratory and Critical Care Medicine;2024-03-28